Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8440170 | CITIUS PHARMS | Orally disintegrating tablets with speckled appearance |
Mar, 2029
(6 years from now) |
Drugs and Companies using PHENTERMINE HYDROCHLORIDE ingredient
Market Authorisation Date: 13 June, 2011
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic